BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35351137)

  • 1. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
    Zhou S; Jiang Y; Liang J; Liu Q
    World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Surg; 2021 Dec; 21(1):441. PubMed ID: 34961494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China.
    Zhou S; Tang J; Liang J; Lou Z; Fu W; Feng B; Yang Y; Xiao Y; Liu Q
    Front Oncol; 2022; 12():916285. PubMed ID: 36033473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
    Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
    BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
    Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
    World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term outcomes of laparoscopic versus open selective lateral pelvic lymph node dissection for locally advanced middle-low rectal cancer: Results of a multicentre lateral node study in China.
    Tang J; Zhou S; Zhao W; Lou Z; Liang J; Feng B; Yang Y; Wang X; Liu Q;
    Colorectal Dis; 2022 Nov; 24(11):1325-1334. PubMed ID: 35713974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and prognostic significance of postoperative complications following lateral pelvic lymph node dissection for rectal cancer: results of the multicenter lateral node study in China.
    Zhou S; Tang J; Mei S; Lou Z; Fu W; Feng B; Yang Y; Sun Y; Liu Q;
    Jpn J Clin Oncol; 2022 Oct; 52(10):1150-1158. PubMed ID: 35858237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
    Hida K; Nishizaki D; Sumii A; Okamura R; Sakai Y; Konishi T; Akagi T; Yamaguchi T; Akiyoshi T; Fukuda M; Yamamoto S; Arizono S; Uemura M; Hasegawa H; Kawada K; Morita S; Watanabe M;
    Ann Surg Oncol; 2021 Oct; 28(11):6179-6188. PubMed ID: 34255243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach.
    Song SH; Choi GS; Kim HJ; Park JS; Park SY; Lee SM; Choi JA; Seok HA
    Tech Coloproctol; 2021 Apr; 25(4):413-423. PubMed ID: 33594627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Selective Lateral Node Dissection Based on Magnetic Resonance Imaging in Rectal Cancer After Preoperative Chemoradiotherapy.
    Park BK; Lee SJ; Hur BY; Kim MJ; Chan Park S; Chang HJ; Kim DY; Oh JH
    J Surg Res; 2018 Dec; 232():227-233. PubMed ID: 30463722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
    Sinukumar S; Engineer R; Saklani A
    Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications.
    Zhou S; Jiang Y; Pei W; Zhou H; Liang J; Zhou Z
    J Surg Oncol; 2021 Sep; 124(3):354-360. PubMed ID: 33882149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
    Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
    Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating predictive factors for determining the presence of lateral pelvic node metastasis in rectal cancer patients following neoadjuvant chemoradiotherapy.
    Wang P; Zhou S; Zhou H; Liang J; Zhou Z
    Colorectal Dis; 2019 Jul; 21(7):791-796. PubMed ID: 30801862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
    Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
    J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy.
    Sakamoto W; Ohki S; Onozawa H; Okayama H; Endo H; Fujita S; Saito M; Saze Z; Momma T; Takenoshita S; Kono K
    J Anus Rectum Colon; 2021; 5(2):129-136. PubMed ID: 33937552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
    Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
    Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thirty years' changes of the strategy of lateral lymph node dissection in low rectal cancer: treatment experience and prognostic analysis of 289 cases in one single center].
    Tang JQ; Li HY; Liu T; Zhang JL; Zuo S; Sun L; Wu YC; Jiang Y; Chen GW; Wu T; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):889-896. PubMed ID: 34674464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.